Share this page on LinkedIn
Share This Page on Google+
Share This Page on Twitter
tell someone about this page print this page
You are here: Contents > 2015 > Volume 24 Number 4 July 2015 > MISCELLANEOUS > The Role of Interleukin-13 in Patients with Rheumatic Valvular Fibrosis: A Clinical and Histological Study

The Role of Interleukin-13 in Patients with Rheumatic Valvular Fibrosis: A Clinical and Histological Study

Qi Liu1,2, Wei-Hua Qiao1, Fei-fei Li1, Peng Deng1, Zhi-Wei Hu1

1Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 2Department of Cardiothoracic Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Background and aim of the study: Interleukin (IL)-13 is a major inducer of fibrosis in many chronic infectious diseases, yet few studies have reported its role in valvular fibrosis in patients with rheumatic heart disease (RHD). The study aim was to investigate the role of IL-13 in mitral valvular fibrosis in patients with RHD.

Methods: Peripheral blood samples were collected from surgical patients with RHD (n = 18) and from healthy controls (n = 9). Serum levels of IL-13 and interferon (IFN)-γ were analyzed using ELISA. Rheumatic mitral valves removed from surgical patients with RHD, and normal mitral valves, were obtained at autopsy. The expression and distribution of collagen I, collagen III, and IL-13Rα1 were examined by immunohistochemical staining, the degree of which was measured using computed imaging analysis.

Results: Higher IL-13 levels were observed in RHD patients (15.16 ± 9.62 pg/ml; p <0.05) than in healthy controls (7.78 ± 3.87 pg/ml). RHD patients had high

levels of IFN-γ (9.95 ± 0.77 pg/ml; p <0.05) compared to healthy controls (5.95 ± 0.69 pg/ml). Immunohistochemistry showed that, compared to normal valves, rheumatic mitral valves expressed high levels of collagen I (0. 01931 ± 0.00159 versus 0.01183 ± 0.00207; p <0.05), collagen III (0.00726 ± 0.00078 versus 0.00342 ± 0.00124; p <0.05), and IL-13Rα1 (0.00454 ± 0.00086 versus 0.00017 ± 0.00008; p <0.01). Collagens I and III were each expressed in heart interstitial cells, while IL-13Rα1 was expressed in the endothelial cells and smooth muscle cells of the blood vessels, and in interstitial cells.

Conclusion: Patients with RHD showed increased serum levels of IL-13 compared to healthy controls. IFN-γ levels were clearly different among RHD patients and healthy controls. The expression of collagens I and III and IL-13Rα1 was higher in rheumatic mitral valves compared to normal mitral valves. IL-13 may induce mitral valvular fibrosis in RHD.

The Journal of Heart Valve Disease 2015;24:496-501

The Role of Interleukin-13 in Patients with Rheumatic Valvular Fibrosis: A Clinical and Histological Study

Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.

Purchase this Article

Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.